BCM
WST icon

Bridgeway Capital Management’s West Pharmaceutical WST Stock Holding History

Bridgeway Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-11,600
Closed -$519K – 1521
2014
Q3 		$519K Buy
11,600
+1,200
+12% +$51K 0.01% 1049
2014
Q2 		$439K Sell
10,400
-1,100
-10% -$47.1K 0.01% 1148
2014
Q1 		$507K Buy
+11,500
New +$541K 0.01% 1073

Other funds holding WST

Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
KI
Kalmar Investments Greenville, Delaware $443M AUM 23.5% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bridgeway Capital Management's WST Position: Q4 2014 in Review

Bridgeway Capital Management sold out of West Pharmaceutical (WST) in Q4 2014, closing a stake of 11,600 shares — an estimated $519K sold.

Bridgeway Capital Management first reported a position in WST in Q1 2014 and held it in 3 quarters. The position peaked at $519K in Q3 2014. 225 funds tracked by Wall St. Rank hold WST as of Q4 2014.

  • Bridgeway Capital Management reported no remaining West Pharmaceutical position as of Q4 2014 after selling out during the quarter.
  • Bridgeway Capital Management sold 11,600 West Pharmaceutical shares in Q4 2014, an estimated $519K.
  • Bridgeway Capital Management first reported a position in West Pharmaceutical in Q1 2014 and held it in 3 quarters.
  • Bridgeway Capital Management's West Pharmaceutical position peaked at $519K in Q3 2014.
  • 225 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2014.

Based on Bridgeway Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.